Clinical Trials Directory

Trials / Completed

CompletedNCT05847998

Second Generation DICART Prototype Validation

Second Generation DICART Prototype Validation for Patients With Acute Circulatory Failure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Capillary refill time (CRT) is a clinical sign for diagnosis of acute circulatory failure and response to treatment but is also associated with prognosis in patient with shock. CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations, depending, for example, on measurement site, pressure applicated or visual evaluation. The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement.

Conditions

Interventions

TypeNameDescription
DEVICEStandardized measurement of capillary refill time by second generation DICART prototypeCapillary refill time is measured by two independent operators, each one blinded from the other, with second generation DICART prototype. Each operator performs two series of three consecutive measurement on the finger. Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax
DIAGNOSTIC_TESTClinical measurement of capillary refill timeCapillary refill time is clinically measured by two independent operators, each one blinded from the other. Each operator performs, two series of three consecutive measurement on the second finger. Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax, inverted relative to DICART measurements.

Timeline

Start date
2023-04-06
Primary completion
2023-10-28
Completion
2023-10-28
First posted
2023-05-08
Last updated
2025-08-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05847998. Inclusion in this directory is not an endorsement.